NUS Engineering team develops novel technology to print customised tablets for personalised medicine

Food and Healthcare Press Releases Thursday May 26, 2016 11:17
SINGAPORE--26 May--PRNewswire/InfoQuest

A team of researchers from the National University of Singapore (NUS) have found a way to make personalised medicine cheaper and easier. Imagine if you could combine the myriad of pills you need to take for your ailment in just one tablet; or if you need only to take the medication once a day and the drug will be slowly released throughout the day at different rates to treat your illness; or if doctors could easily make tablets on the spot that are tailored to each patient's needs.

http://photos.prnasia.com/prnvar/20151130/8521508170LOGO

All these could become a reality with a new method of tablet fabrication designed by Assistant Professor Soh Siowling and PhD student Ms. Sun Yajuan from the Department of Chemical and Biomolecular Engineering at the NUS Faculty of Engineering. The novel system can make customisable pills that release drugs with any desired release profiles.

Customised tablets for optimal therapeutic results
Releasing drugs in a timely manner is important for optimal therapeutic effect in the human body. Different types of clinical circumstances may call for different types of timed release of drugs.

While there are some existing tablet-production methods, including 3D printing, that can allow certain flexibility, they have their limitations -- low dosage, release profiles that are non-continuous, or the drugs are released in a large burst in the initial stage, and poor durability of the tablet given its quick breakdown. These methods are also only able to fabricate tablets that release drugs with a limited type of profiles.

A fully customisable fabrication method

"For a long time, personalised tablet has been a mere concept as it was far too complex or expensive to be realised. This new tablet fabrication method is a game changer -- it is technically simple, relatively inexpensive and versatile. It can be applied at individualised settings where physicians could produce customised pills on the spot for patients, or in mass production settings by pharmaceutical companies," said Asst Prof Soh.

Instead of manufacturing the drug tablet by printing layer by layer, the drug tablet designed by the NUS team consists of three components, including a polymer containing the drug in a specifically designed shape that will determine the rate of release of the drug. By adjusting the shape of the drug-containing polymer, it is thus possible to release drugs at any desired rate.

Using the system designed by the NUS team, a doctor only needs to draw the desired release profile in a computer software to generate a template for making tablets specific to a patient's treatment, which can then be used to easily produce the desired pills using a 3D printer. The system is easy to use and does not involve any complex mathematical computation whenever a new release profile is needed. The fully customisable system is able to create a template to print tablets for any release profile.

The use of a commercially available 3D printer in this method also makes it a relatively cheap way of making personalised medicine a reality.

In drug delivery, it is also important to administer more than one type of drug into the human body simultaneously to treat an illness. This fabrication method can also be modified to include multiple types of drugs loaded within the same tablet -- and more importantly, each drug can be customised to release at different rates even within the same tablet.

For more information: http://news.nus.edu.sg/press-releases/10439-customised-tablets-personalised-medicine
Logo - http://photos.prnasia.com/prnh/20151130/8521508170LOGO

Latest Press Release

Osotspa joins with Banphaeo Hospital to provide free surgeries to give sight back to patients with cataracts

Osotspa Public Company Limited has joined together with Banphaeo Hospital to give senior citizens and the underprivileged in remote areas who needed cataract surgery their sight back so they can resume living normal lives, an initiative that reflects the...

Financial year 2018: Boehringer Ingelheim grows and invests

- Well-filled research pipeline in oncology, fibrotic diseases, immunology and metabolic diseases - Operating growth outpaces the market in all businesses - Technical integration of the animal health business acquired in 2017 successfully completed The...

#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma#s Empowering Rosacea Awareness Month Social Media Campaign

As part of its ongoing commitment to raising awareness of rosacea and the hidden burden of the disease, Galderma is collaborating with top social media influencers this Rosacea Awareness Month, to encourage people with rosacea to speak up and share...

Galderma Marks Rosacea Awareness Month With New Insights Into Why Some Patients Are Self-treating and Launches Social Media Campaign to Reinforce Hidden Impact of the Disease

Galderma extends its commitment to understanding the beyond the visible impact of rosacea with new patient insights supporting healthcare professionals' understanding of patient behavior and revealing possible motivations for not reconsulting Building...

Sun Life Financial Asia Releases New Diabetes in Asia Report

More than 60% of diabetics live in Asia; Community-based approach needed to create opportunities for change A coordinated, community-based approach is essential to hold back the rising tide of diabetes in Asia, according to a new report from Sun Life...

Related Topics